PR96846

MIAMI LAKES, Fla., July 8, 2022 /PRNewswire=KYODO JBN/ --

--Seasoned medical technology leader tapped to maximize momentum in APAC

Cordis, a global leader in cardiovascular technologies, today announced that

Bryan Loo will assume the role of President of the Asia-Pacific (APAC) region

effective July 18, 2022. Loo will head a leadership team responsible for

commercial and clinical strategy, business operations, and teammate development

in the company's fast-growing APAC region.

Photo - https://mma.prnewswire.com/media/1852408/Cordis_Bryan_Loo.jpg

Logo - https://mma.prnewswire.com/media/1676076/Cordis_Logo.jpg

"We are pleased to welcome Bryan to the team," said Cordis CEO Shar Matin. "He

brings a depth of leadership and customer relationship-building experience in

the APAC medical technology and healthcare markets that spans decades. He has a

reputation for relentless execution and growing high-performing teams that

produce results for the business and build strong relationships with physician

customers."

Loo joins Cordis from Genesis Medtech, where he served as President and built

the infrastructure for its vertically integrated, open-platform model. During

his tenure at Asia Pacific Danaher Dental as President and Bayer Radiology as

APAC Vice-President, he built a reputation for pivoting businesses to

double-digit growth. He also previously held multiple roles at Cordis over a

16-year period, when it was a part of J&J Medical, including Vice President of

Cordis China, delivering the largest revenue and highest profit in the division.

"I am honored to rejoin this new, reenergized Cordis team," said Loo. "Its

legacy of providing trusted, differentiated solutions that improve patients'

lives is unmatched, and now I see a compelling opportunity to participate in a

new era of innovation and transformation that is possible as an independent

Cordis."

According to Matin, Loo will leverage his deep roots in Asia to grow customer

relationships and attract top talent that aligns with his vision for symbiotic

teams that are inspired by the pioneering spirit that built Cordis over the

past 60 years and is being rediscovered today.

Loo will be based in Singapore. He is a Business graduate of Nanyang

Technological University and benefitted from executive leadership programs in

Harvard Business School and INSEAD.

About Cordis

Cordis is a worldwide leader in the development and manufacturing of

interventional vascular technology with a more than 60-year history of

pioneering breakthrough cardiovascular technologies to treat millions of

patients. With a reputation for clinical acumen, training, and services, Cordis

established a legacy of innovation in high-quality and less-invasive

cardiovascular products and built a strong global footprint with operations in

more than 70 countries around the world.

Media contact:

Margaret-Sarah Alexander

Vice President, Head of Global Strategic Marketing

margaretsarah.alexander@cordis.com

m. +1 203-297-4182

SOURCE: Cordis